BioPower Operations Corporation
BOPO
$0.0001
$0.000.00%
| 05/31/2023 | 02/28/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8,635.56% | -87.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 871.69% | 21.96% | |||
| Operating Income | -871.69% | -21.96% | |||
| Income Before Tax | -655.61% | -17.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -655.61% | -17.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -655.61% | -17.27% | |||
| EBIT | -871.69% | -21.96% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -651.45% | -15.97% | |||
| Normalized Basic EPS | -653.49% | -16.22% | |||
| EPS Diluted | -651.45% | -15.97% | |||
| Normalized Diluted EPS | -653.49% | -16.22% | |||
| Average Basic Shares Outstanding | 0.53% | 0.71% | |||
| Average Diluted Shares Outstanding | 0.53% | 0.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
